Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Suven Life Sciences Limited per 2025 Jun 30 adalah 75.17 MM.
- Nilai operating income untuk Suven Life Sciences Limited per 2025 Jun 30 adalah -1,912.84 MM.
- Nilai net income untuk Suven Life Sciences Limited per 2025 Jun 30 adalah -1,842.22 MM.
Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
2025-06-30 | 75.17 | -1,912.84 | -1,842.22 |
2025-03-31 | 66.56 | -1,711.92 | -1,607.45 |
2024-12-31 | 75.74 | -1,580.10 | -1,433.41 |
2024-09-30 | 84.15 | -1,650.66 | -1,459.89 |
2024-06-30 | 89.02 | -1,366.38 | -1,090.26 |
2024-03-31 | 116.93 | -1,342.92 | -1,050.76 |
2023-12-31 | 119.74 | -1,353.92 | -1,061.81 |
2023-09-30 | 125.26 | -1,408.53 | -1,155.31 |
2023-06-30 | 138.53 | -1,389.34 | -1,260.32 |
2023-03-31 | 135.95 | -1,319.16 | -1,182.68 |
2022-12-31 | 152.56 | -1,194.88 | -1,114.21 |
2022-09-30 | 166.86 | -999.33 | -939.96 |
2022-06-30 | 134.84 | -1,052.66 | -991.13 |
2022-03-31 | 119.51 | -1,262.16 | -1,219.95 |
2021-12-31 | 97.75 | -1,274.84 | -1,228.09 |
2021-09-30 | 68.55 | -1,216.17 | -1,135.12 |
2021-06-30 | 146.51 | -1,116.05 | -1,008.70 |
2021-03-31 | 140.73 | -832.85 | -721.51 |
2020-12-31 | 208.72 | -873.18 | -760.97 |
2020-09-30 | 221.31 | -880.94 | -745.18 |
2020-06-30 |
Laporan Laba Rugi: EPS
Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
2025-06-30 | ||
2025-03-31 | ||
2024-12-31 | -6.58 | -6.58 |
2024-09-30 | -6.68 | -6.69 |
2024-06-30 | -5.01 | -5.01 |
2024-03-31 | -4.82 | -4.82 |
2023-12-31 | -4.88 | -4.88 |
2023-09-30 | -5.39 | -5.38 |
2023-06-30 | -6.41 | -6.41 |
2023-03-31 | -6.63 | -6.63 |
2022-12-31 | -7.38 | -7.38 |
2022-09-30 | -6.89 | -6.89 |
2022-06-30 | -7.50 | -7.50 |
2022-03-31 | -9.05 | -9.05 |
2021-12-31 | -9.65 | -9.65 |
2021-09-30 | -8.92 | -8.93 |
2021-06-30 | -7.93 | -7.94 |
2021-03-31 | -5.67 | -5.67 |
2020-12-31 | -5.98 | -5.98 |
2020-09-30 | -5.85 | -5.85 |
2020-06-30 | -6.17 | -6.17 |
Arus Kas: Operasi, Investasi, Pendanaan
Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
2025-06-30 | |||
2025-03-31 | -1,541.05 | 1,549.54 | -7.56 |
2024-12-31 | |||
2024-09-30 | -1,487.84 | 1,386.68 | -10.31 |
2024-06-30 | |||
2024-03-31 | -826.19 | 944.36 | -10.54 |
2023-12-31 | |||
2023-09-30 | -978.02 | -2,468.03 | 3,463.99 |
2023-06-30 | |||
2023-03-31 | -1,031.48 | -2,606.45 | 3,955.39 |
2022-12-31 | |||
2022-09-30 | -872.98 | -555.10 | 1,484.67 |
2022-06-30 | |||
2022-03-31 | -1,275.37 | -222.29 | 1,456.92 |
2021-12-31 | |||
2021-09-30 | -1,262.31 | 539.01 | 818.10 |
2021-06-30 | |||
2021-03-31 | -960.24 | 558.40 | 348.56 |
2020-12-31 | |||
2020-09-30 | -1,477.90 | 1,468.51 | 16.66 |
2020-06-30 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- p/e untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah -36.23.
- p/libro untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah 47.21.
- p/tbv untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah 47.29.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
Period End (TTM) | p/e | P/Book | P/TBV |
2025-06-30 | -36.23 | 47.21 | 47.29 |
2025-03-31 | -17.66 | 13.14 | 13.15 |
2024-12-31 | -19.19 | 14.54 | 14.56 |
2024-09-30 | -28.84 | 11.65 | 11.65 |
2024-06-30 | -21.40 | 8.33 | 8.33 |
2024-03-31 | -20.48 | 6.42 | 6.43 |
2023-12-31 | -44.35 | 15.14 | 15.15 |
2023-09-30 | |||
2023-06-30 | |||
2023-03-31 | |||
2022-12-31 | |||
2022-09-30 | |||
2022-06-30 | |||
2022-03-31 | -18.39 | 45.34 | 45.56 |
2021-12-31 | -19.98 | 45.52 | 45.74 |
2021-09-30 | -25.21 | 23.55 | 23.58 |
2021-06-30 | -16.32 | 15.24 | 15.26 |
2021-03-31 | -45.64 | 30.49 | 30.53 |
2020-12-31 | -43.27 | 28.12 | 28.16 |
2020-09-30 | -15.69 | 28.12 | 28.16 |
2020-06-30 | -12.58 | 11.49 | 11.50 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
- EBIT/EV untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah -0.03.
- EBIT (3 tahun) / EV untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah -0.02.
Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
2025-06-30 | -0.03 | -0.02 |
2025-03-31 | -0.06 | -0.05 |
2024-12-31 | -0.05 | -0.04 |
2024-09-30 | -0.04 | -0.04 |
2024-06-30 | -0.05 | -0.06 |
2024-03-31 | -0.05 | -0.06 |
2023-12-31 | -0.02 | -0.02 |
2023-09-30 | -0.09 | -0.08 |
2023-06-30 | -0.11 | -0.10 |
2023-03-31 | -0.09 | -0.08 |
2022-12-31 | -0.07 | -0.12 |
2022-09-30 | -0.10 | -0.17 |
2022-06-30 | -0.11 | -0.12 |
2022-03-31 | -0.05 | -0.05 |
2021-12-31 | -0.05 | -0.02 |
2021-09-30 | -0.04 | 0.01 |
2021-06-30 | -0.06 | -0.02 |
2021-03-31 | -0.02 | -0.00 |
2020-12-31 | -0.02 | -0.00 |
2020-09-30 | -0.09 | 0.02 |
2020-06-30 | -0.11 | 0.04 |
Efektivitas Manajemen
- roa untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah -0.50.
- roe untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah -0.68.
- roic untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah -1.30.
- croic untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah 0.00.
- ocroic untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah 0.00.
Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
2025-06-30 | -0.50 | -0.68 | -1.30 | 0.00 | 0.00 |
2025-03-31 | -0.41 | -0.42 | -0.74 | -0.06 | -0.77 |
2024-12-31 | -0.42 | -0.42 | -0.76 | -0.06 | -0.77 |
2024-09-30 | -0.31 | -0.43 | -0.40 | -0.08 | -0.31 |
2024-06-30 | -0.27 | -0.28 | -0.39 | -0.08 | -0.31 |
2024-03-31 | -0.88 | -1.88 | -0.31 | 0.01 | -0.29 |
2023-12-31 | -0.96 | -2.05 | -0.34 | 0.01 | -0.33 |
2023-09-30 | -1.17 | -1.31 | -0.33 | 0.00 | 0.00 |
2023-06-30 | -1.09 | -1.31 | -0.33 | 0.08 | -0.27 |
2023-03-31 | -1.03 | -1.23 | -0.28 | 0.07 | -0.24 |
2022-12-31 | -1.50 | -1.89 | -0.87 | 0.05 | -0.81 |
2022-09-30 | -1.58 | -1.89 | -1.60 | 0.10 | -1.48 |
2022-06-30 | -0.95 | -0.92 | -1.00 | -0.04 | -1.28 |
2022-03-31 | -0.96 | -1.13 | -1.22 | -0.04 | -1.28 |
2021-12-31 | -0.80 | -0.97 | -2.28 | 0.18 | -2.35 |
2021-09-30 | -0.80 | -0.97 | -2.09 | 0.17 | 0.00 |
2021-06-30 | -0.55 | -0.70 | -0.89 | -0.05 | -0.85 |
2021-03-31 | -0.40 | -0.50 | -0.65 | -0.05 | -0.86 |
2020-12-31 | -0.06 | -0.08 | -0.63 | -0.36 | -2.32 |
2020-09-30 | -0.17 | -0.23 | -1.71 | -0.36 | -1.21 |
2020-06-30 | -0.13 | -0.16 | -0.88 | 0.10 | -0.90 |
Gross Margins
- marjin kotor untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah 0.89.
- marjin bersih untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah -18.93.
- marjin operasi untuk Suven Life Sciences Limited pada 2025 Jun 30 adalah -20.86.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
2025-06-30 | 0.89 | -18.93 | -20.86 |
2025-03-31 | 0.89 | -18.93 | -20.86 |
2024-12-31 | 0.90 | -17.35 | -19.62 |
2024-09-30 | 0.91 | -12.25 | -15.35 |
2024-06-30 | 0.95 | -8.99 | -11.50 |
2024-03-31 | 0.95 | -8.87 | -11.31 |
2023-12-31 | 0.95 | -9.22 | -11.25 |
2023-09-30 | 0.96 | -9.10 | -10.04 |
2023-06-30 | 1.00 | -9.10 | -10.04 |
2023-03-31 | 0.84 | -8.74 | -9.78 |
2022-12-31 | 0.85 | -5.63 | -5.99 |
2022-09-30 | 0.82 | -5.63 | -5.99 |
2022-06-30 | 1.00 | -7.35 | -7.81 |
2022-03-31 | 0.99 | -10.30 | -10.70 |
2021-12-31 | 0.98 | -12.56 | -13.05 |
2021-09-30 | 0.99 | -16.56 | -17.74 |
2021-06-30 | 0.99 | -6.89 | -7.62 |
2021-03-31 | 0.99 | -5.13 | -5.92 |
2020-12-31 | 1.00 | -3.65 | -4.19 |
2020-09-30 | 1.00 | 0.47 | 0.68 |
2020-06-30 | 0.64 | 0.72 | 1.03 |
Pengenal dan Deskriptor
Kunci Indeks Pusat (CIK) |